MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....distribution, crystallinity, dose content uniformity, microbial content, and stability.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)
...What processes in biological drug manufacturing would benefit the most from implementation.....For processes or products that do not currently allow direct product quality monitoring.....Parametric Tolerance Interval Test (PTIT) for Dose Content Uniformity of Aerosol Products..
http://www.fda.gov/ohrms/dockets/ac/04/minutes/4034M1.DOC (score=46)
...60 1 The test we have for dose content 2 uniformity or delivered dose uniformity for 3.....22 Immediate applications I think may be more 23 likely in terms of drug product manufacturing.....We may use it to meet 7 the regulatory specifications to release a drug 8 product, we may apply..
http://www.fda.gov/ohrms/dockets/ac/04/transcripts/4034T1.DOC (score=39)
FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...To qualify for these statutory exemptions, a compounded drug product must satisfy several.....Metered dose inhalers are sophisticated drug delivery systems that require extensive.....Generally, adequate tests measurecontent, content uniformity of the active ingredient..
http://www.fda.gov/cder/fdama/difconc.htm (score=23)
Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products...
...This test involves determining the dose content uniformity at the beginning of unit life, at.....The guidance sets forth information that should be provided to ensure continuing drug product.....The recommendations for acceptance criteria and tests for emitted dose content uniformity from..
http://www.fda.gov/CDER/GUIDANCE/2180dft.htm (score=22)
Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products...
...This test involves determining the dose content uniformity at the beginning of unit life, at.....The guidance sets forth information that should be provided to ensure continuing drug product.....The recommendations for acceptance criteria and tests for emitted dose content uniformity from..
http://www.fda.gov/cder/guidance/2180dft.htm (score=22)
file://///Tiffanie/C/storage/0413PHAR.TXT
...23 likely in terms of drug product manufacturing, 24 measuring of more single types of process.....19 gone through, that you have real-time monitoring, 20 and not just of a unit dose sample.....6 to I think the content uniformity issue, and, 7 third, I guess in general, other..
http://www.fda.gov/ohrms/dockets/ac/04/transcripts/4034T1.pdf (score=20)
þÿ
...Parametric Tolerance Interval Test for Dose Content Uniformity, and discussed the.....The Advisory Committee for Pharmaceutical Science of the Food and Drug Administration.....For processes or products that do not currently allow direct product quality monitoring..
http://www.fda.gov/ohrms/dockets/ac/04/minutes/4034M1.pdf (score=20)
stability guidance -draft
...provided as part of the drug product specifications for the chemical content of preservatives.....when significant change in aerodynamic particle size distribution or in dose content uniformity.....this guidance to mean a batch of drug substance or drug product manufactured at the scale typically encountered..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=18)
...The first, dose content uniformity through container life, our working group has recommended.....Clearly, a drug product that was being developed would have to be very, very different from the.....In the case of the nasal spray products, in addition to the drug, the product contains inactive..
http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3764t1.txt (score=13)
...The first, dose content uniformity through container life, our working group has recommended.....Clearly, a drug product that was being developed would have to be very, very different from the.....In the case of the nasal spray products, in addition to the drug, the product contains inactive..
http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3764t1.htm (score=13)
...The drug product should also be maintained in the sponsor's and/or manufacturer's original.....Dose content uniformity or spray content uniformity release tests alone usually take 30.....It is usually the innovator's product or a marketed product of the drug under..
http://www.fda.gov/cder/guidance/5522fnl.doc (score=12)
Microsoft Word - 5522fnl.doc
...standard before sending the drug product to the testing facility.4 This is to ensure that.....provided to the testing facility in unit dose packaging with each unit dose labeled with a.....Dose content uniformity or spray content uniformity release tests..alone usually take 30..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2002d-0350-gdl0002.pdf (score=12)
Microsoft Word - 5522fnl.doc
...standard before sending the drug product to the testing facility.4 This is to ensure that.....provided to the testing facility in unit dose packaging with each unit dose labeled with a.....Dose content uniformity or spray content uniformity release tests..alone usually take 30..
http://www.fda.gov/cder/guidance/5522fnl.pdf (score=12)
...Release of the drug from the drug product produces droplet or drug particle sizes and distribution patterns.....Dose content uniformity or spray content uniformity release tests alone usually require 30.....From a product quality perspective, the critical issues are release of drug substance from drug product and..
http://www.fda.gov/cder/guidance/5383DFT.doc (score=12)
BA/BE studies for Nasal Aerosols and Nasal Sprays for Local Ac
...test such as dose content uniformity has acceptance criteria based on repeated manufacturing of.....information that pertains to the identity, strength,quality, purity, and potency of a drug.....affect the BA of the drug product as a result of different solubilities and/or rates of..
http://www.fda.gov/cder/guidance/2070dft.pdf (score=12)
...An adverse reaction is a noxious and unintended response to any dose of a drug product for which there is.....The Need for Revised Prescription Drug Labeling Although the format and content requirements for prescription drug labeling in.....All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug..
http://www.fda.gov/OHRMS/DOCKETS/98fr/122200a.htm (score=8)
IND content and format for Phase 1 studies
...As clinical development of a drug product proceeds,sponsors should discuss the manufacturing.....exclusions; and a description of the dosing plan, including duration,dose, or method to be.....and the general requirements for an IND's content and format. III. CLARIFICATIONS OF..
http://www.fda.gov/cder/guidance/phase1.pdf (score=8)
þÿ
...Aerosol Steroid Product Safety Information in Prescription Drug Advertising and.....Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy.....Format and Content of the Human Pharmacokinetics and Bioavailability Section of an..
http://www.fda.gov/cder/guidance/guidlist.pdf (score=4)
Selected Guidance Documents Applicable to Combination Products
...Content of Investigational New Drug Applications for Phase I Studies of Drugs Including Well Characterized, Therapeutic.....Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy.....As an aid to sponsors seeking to develop a combination product, the Office of Combination..
http://www.fda.gov/oc/combination/guidance.html (score=4)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer
